BMC Women's Health - Latest articlesThe latest articles from BMC Women's Health (ISSN 1472-6874) published by BioMed CentralThe METEX study: methotrexate versus expectant management in women with ectopic pregnancy: a randomised controlled trial.- June 19, 2008 Background: Patients with ectopic pregnancy (EP) and low serum hCG concentrations and women with a pregnancy of unknown location (PUL) and plateauing serum hCG levels are commonly treated with systemic methotrexate (MTX). However, there is no evidence that treatment in these particular subgroups of women is necessary as many of these early EPs may resolve spontaneously. The aim of this study is whether expectant management in women with EP or PUL and with low but plateauing serum hCG...http://www.biomedcentral.com/1472-6874/8/10 |